Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells
According to the judgement of the European Court of Justice in 2014, human parthenogenetic stem cells are excluded from the patenting prohibition of procedures based on hESC by the European Biopatent Directive, because human parthenotes are not human embryos. This article is based on the thesis that...
| Auteurs: | ; ; |
|---|---|
| Type de support: | Électronique Article |
| Langue: | Anglais |
| Vérifier la disponibilité: | HBZ Gateway |
| Journals Online & Print: | En cours de chargement...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Publié: |
Wiley-Blackwell
[2017]
|
| Dans: |
Bioethics
Année: 2017, Volume: 31, Numéro: 5, Pages: 409-417 |
| Classifications IxTheo: | NBE Anthropologie NCH Éthique médicale |
| Sujets non-standardisés: | B
Human Dignity
B European Court of Justice B human parthenotes B commercial use B totipotency B hESC B Human embryo |
| Accès en ligne: |
Accès probablement gratuit Volltext (Verlag) Volltext (doi) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1727655680 | ||
| 003 | DE-627 | ||
| 005 | 20210902111310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200824s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12334 |2 doi | |
| 035 | |a (DE-627)1727655680 | ||
| 035 | |a (DE-599)KXP1727655680 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |e VerfasserIn |0 (DE-588)1154329208 |0 (DE-627)1015594131 |0 (DE-576)50069124X |4 aut |a Schickl, Hannah | |
| 109 | |a Schickl, Hannah | ||
| 245 | 1 | 0 | |a Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells |
| 264 | 1 | |c [2017] | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a According to the judgement of the European Court of Justice in 2014, human parthenogenetic stem cells are excluded from the patenting prohibition of procedures based on hESC by the European Biopatent Directive, because human parthenotes are not human embryos. This article is based on the thesis that in light of the technological advances in the field of stem cell research, the attribution of the term ‘human embryo’ to certain entities on a descriptive level as well as the attribution of a normative protection status to certain entities based on the criterion of totipotency, are becoming increasingly unclear. The example of human parthenotes in particular demonstrates that totipotency is not at all a necessary condition for the attribution of the term ‘human embryo’. Furthermore, the example of hiPSC and somatic cells particularly shows that totipotency is also not a sufficient condition for the attribution of a normative protection status to certain entities. Therefore, it is not a suitable criterion for distinguishing between human embryos worthy of protection and human non-embryos not worthy of protection. Consequently, this conclusion has repercussions for the patenting question. The strict delineation between an ethically problematic commercial use of human embryos and the concomitant patenting prohibition of hESC-based procedures and an ethically unproblematic commercial use of human non-embryos and the therefore either unrestrictedly permitted (cf. human parthenotes) or even unregulated (cf. hiPSC) patenting of procedures based on these alleged alternatives becomes increasingly blurred. | ||
| 601 | |a Prohibition | ||
| 650 | 4 | |a European Court of Justice | |
| 650 | 4 | |a commercial use | |
| 650 | 4 | |a hESC | |
| 650 | 4 | |a Human Dignity | |
| 650 | 4 | |a Human embryo | |
| 650 | 4 | |a human parthenotes | |
| 650 | 4 | |a totipotency | |
| 652 | |a NBE:NCH | ||
| 700 | 1 | |e VerfasserIn |0 (DE-588)114170169 |0 (DE-627)501838112 |0 (DE-576)175302707 |4 aut |a Dabrock, Peter |d 1964- | |
| 700 | 1 | |e VerfasserIn |0 (DE-588)1076755712 |0 (DE-627)835298965 |0 (DE-576)445636289 |4 aut |a Braun, Matthias |d 1984- | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 31(2017), 5, Seite 409-417 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2017 |g number:5 |g pages:409-417 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12334 |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via crossref license)] | ||
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12334 |x Verlag |
| 856 | |u https://doi.org/10.1111/bioe.12334 |x doi |3 Volltext | ||
| 936 | u | w | |d 31 |j 2017 |e 5 |h 409-417 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 3742292455 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1727655680 | ||
| LOK | |0 005 20210902111310 | ||
| LOK | |0 008 200824||||||||||||||||ger||||||| | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixzo | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 144205168X |a NBE | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||